Active Ingredient: CISATRACURIUM BESYLATE
Proprietary Name: CISATRACURIUM BESYLATE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 10MG BASE/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A212432
Product Number: 002
Approval Date: Mar 11, 2022
Applicant Holder Full Name: PIRAMAL HEALTHCARE UK LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information
